Health Care & Life Sciences » Pharmaceuticals | Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc. | Ownership

Companies that own Marinus Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Jennison Associates LLC
2,757,356
6.8%
21,733
0.02%
06/30/2018
Granite Point Capital Management LP
2,638,321
6.51%
0
7.56%
06/30/2018
BlackRock Fund Advisors
2,469,469
6.09%
1,834,820
0%
06/30/2018
Franklin Advisers, Inc.
1,928,085
4.76%
260,500
0.01%
06/30/2018
Three Bays Capital LP
1,905,469
4.7%
961,169
1.38%
06/30/2018
The Vanguard Group, Inc.
1,502,943
3.71%
208,024
0%
06/30/2018
683 Capital Management LLC
1,200,000
2.96%
0
0.98%
06/30/2018
Perceptive Advisors LLC
907,732
2.24%
0
0.15%
06/30/2018
OrbiMed Advisors LLC
567,600
1.4%
0
0.04%
06/30/2018
SSgA Funds Management, Inc.
550,774
1.36%
508,755
0%
06/30/2018

About Marinus Pharmaceuticals

View Profile
Address
170 North Radnor Chester Road
Radnor Pennsylvania 19087
United States
Employees -
Website http://www.marinuspharma.com
Updated 07/08/2019
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the identification and development of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded by Geoffrey E.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.